chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A non-serious spontaneous report of fever, cough, congestion and runny nose has been received from a health professional concerning an eight-year-old male, subsequent to FLUMIST. The patient's medical history included breathing treatments off and on, allergies and asthma like symptoms. Concomitant medications have not been reported for this patient. The patient received FLUMIST on 24-Aug-2011. After receiving FLUMIST, the patient developed runny nose, congestion and cough on 26-Aug-2011. The patient had fever on 10-Sep-2011 of 102. The reporter stated that the patient had visited to his pediatrician for all the adverse events. It was not confirmed if the patient had a clear diagnosis of asthma. The outcome of events fever, cough, congestion and runny nose was resolved on 14-Sep-2011. Additional information was received on 14-Dec-2011 and incorporated into the narrative: medical history and outcome of the event.
Flu vaccine administered at 11AM, 8 hrs later had seizure asthma episode 911 was called, dx'd at ER, sent home same day.
had episode of urticaria 24hrs p/vax;was seen by MD felt to be possible rxn to vax
Expired vaccine received; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021 at 1:29 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021 at 1:29 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine received). On 24-Sep-2021 at 1:29 PM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.  The patient did not have any adverse events and did not require any medical attention after receiving the dose.
At about the 12 hour mark, extreme body aches and nausea began. At the 16 hour mark, fever over 103 set in. Fever and body aches continued for 24 hours.
Starting at around 4PM, patient started complaining of nausea. He refused dinner at around 6pm. By 6:30, he developed a fever of 102F. At 7, he started vomiting. He couldn't keep down water or antipyretics. This continued into the morning. I called his physician's office, and they called in Zofran. I was able to give that to him at noon. The nausea subsided. The fever reimagined until approximately 6pm on 3/9/2016.
started passing out randomly and said that she's been experiencing them too; the vaccines changed her DNA composition and her DNA molecular structure; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant), outcome "unknown", described as "started passing out randomly and said that she's been experiencing them too"; GENE MUTATION (non-serious), outcome "unknown", described as "the vaccines changed her DNA composition and her DNA molecular structure". Clinical course: Caller wanted to know the chemical composition of the Pfizer Covid-19 Vaccine. Caller wanted to know why the vaccines were not yet approved by the FDA. She stated that she had been experiencing some serious side effects after the vaccine. She said that she started passing out randomly. She wanted to know if Pfizer employees were experiencing them too or if even Pfizer employees took the Pfizer Covid-19 vaccines. Caller also was not sure if she was going to live for another three or five years because of the vaccines because she said that the vaccines changed her DNA composition and her DNA molecular structure. She said that the vaccines gave her a third helix on her DNA.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300108344 same reporter and drug, different patient and event;
Eleveated temperature, lots of congestion, eyes mattery, yellow mucous in eye, nasal drainage thick yellow, chest congested, red TM, throat red, rhonchi wheezing, min. retracting.
This spontaneous report as received from a nurse refers to 9 unspecified patients received doses of GARDASIL (lot H012643, exp 30-MAR-2015) on unspecified dates, that were exposed to the same temperature excursion(28.8F for 8 minutes). No adverse effect reported. This is one of several reports received from the same source (related case # 137USA015230). Additional information has been requested.
Swollen arm; red arm; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced swelling arm and erythema of extremities. On an unknown date, the outcome of the swelling arm and erythema of extremities were unknown.   It was unknown if the reporter considered the swelling arm and erythema of extremities to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient stated that after vaccination arm was swollen and red. The patient asked how long would arm be swollen and red from the shingles shot.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Sep2023) Positive; (unspecified date) Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 included nirmatrelvir; ritonavir (PAXLOVID) oral from 23Aug2023 to 27Aug2023. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Loss of appetite; Severe GI pain; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single, manufacture: Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 2, single, manufacture: Unknown), for COVID-19 Immunization. The following information was reported: DECREASED APPETITE (non-serious), outcome "unknown", described as "Loss of appetite"; GASTROINTESTINAL PAIN (non-serious), outcome "unknown", described as "Severe GI pain". The events "loss of appetite" and "severe gi pain" required emergency room visit.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
When I got up the morning after the second vaccine, I felt dizzy and sluggish. Checked my pulse, my HR was 42. BP a little higher than normal but okay. My eyes felt blurry and as though there was a film of vaseline over them and they were both very red, like pinkeye, and also sore. I had a headache which is extremely unusual for me. I also had a feeling of generalized malaise. Before this, despite being a senior and diabetic, I felt great. Wonderful! Haven't had so much as a cold for 14 years. I am not a big believer in coincidence.
Received moderna vaccine 12/29/20. Have had pain in left shoulder since receiving and  Intermittent tingling In hand.  Issue continued as of reporting 1/14/21.
Should have received moderna 6mo-4yr; This is a spontaneous report received from contactable reporter(s) (Nurse).  A 4-year-old male patient received BNT162b2 (BNT162B2), on 01Jul2022 at 17:30 as dose 1, single (Lot number: FL8094) intramuscular, in left arm for covid-19 immunisation. The patient didn't receive coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 01Jul2022, outcome "unknown", described as "Should have received moderna 6mo-4yr".
I was on day 2 ( about 30 hours in) of my period and it just stopped a few hours after getting my second dose. Had a little spotting but my period is usually 4 solid days.
Sun I woke in middle of night with pain in thumb. There was nothing there. When I got up few hours later my thumb on left hand had enormous blood blister.  Which immediately grew, was infected, and whole hand swelled up.  Wednesday night I had same pain under right eye. Again nothing was there. Few hours later my eye was all swollen.  I have another Dr appt tomorrow with Dr.  I had the emergency room take care of my thumb. That Dr, Dr  , a few days later sent me to Dr.
3 to 4 hr after injection developed severe pain in arm - seen in ED at Medical Center. Treated with BENADRYL, Prednisone, Epi.
4" red streak behind (L) arm where vaccine was administered. Arm sore all the way up into her left breast. Nausea, aching for 3 days.
NUMBNESS ON THE TIPS OF FINGERS ON LEFT HAND; UNEASY; FLUTTERY CHEST; SORENESS AT INJECTION SITE; ANXIOUS/MILD ANXIETY; MIGRAINE; BODY ACHE; TIRED; This spontaneous report received from a patient concerned a 39 year old female. The patient's weight was 140 pounds, and height was 65 inches. The patient's past medical history included marijuana abuse, and concurrent conditions included no alcohol use, non smoker, and hypothyroidism, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient experienced drug allergy when treated with aminobenzoic acid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) .5 ml, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included levothyroxine for hypothyroidism, escitalopram oxalate, and ethinylestradiol/etonogestrel. On 07-APR-2021, the subject experienced migraine. On 07-APR-2021, the subject experienced body ache. On 07-APR-2021, the subject experienced tired. On 07-APR-2021 06:00, treatment medications included: ibuprofen. On 08-APR-2021, the subject experienced anxious/mild anxiety. On 08-APR-2021, the subject experienced soreness at injection site. On 09-APR-2021, the subject experienced fluttery chest. On 16-APR-2021, the subject experienced uneasy. On 16-APR-2021 10:00, the subject experienced numbness on the tips of fingers on left hand. On 17-APR-2021, treatment medications included: caffeine/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache on 08-APR-2021, anxious/mild anxiety on 13-APR-2021, numbness on the tips of fingers on left hand on 16-APR-2021, fluttery chest on APR-2021, and soreness at injection site on 09-APR-2021, and had not recovered from migraine, tired, and uneasy. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
After vaccine admin, pt. walking and felt lightheaded, lost consciousness for a few seconds, struck nose and face on door knob and stiffened, father caught and placed on bed, child aroused and observed for 45 min.
Low fever under 100 Fahrenheit degrees; Swollen lymph node on left arm pit/felt the lymph node was starting to swell; Feeling tired; Feeling horrible; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (Low fever under 100 Fahrenheit degrees), LYMPHADENOPATHY (Swollen lymph node on left arm pit/felt the lymph node was starting to swell), FATIGUE (Feeling tired) and FEELING ABNORMAL (Feeling horrible) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054A22A) for COVID-19 vaccination.     Patient had no allergies. Patient never tested positive for Covid-19.  Previously administered products included for Product used for unknown indication: Pfizer (1st dose, Lot: EN6201) on 16-Feb-2021, Pfizer (2nd Dose, Lot: EN6208) on 09-Mar-2021, flu vaccine in October 2021, flu vaccine in October 2021, flu vaccine in October 2021, flu vaccine in October 2021, Pfizer (1st Booster dose and Lot: FF2593) on 01-Dec-2021. Past adverse reactions to the above products included Feeling abnormal with flu vaccine; Low grade fever with flu vaccine; No adverse event with Pfizer, Pfizer and Pfizer; Swollen lymph nodes with flu vaccine; and Tiredness with flu vaccine. Concomitant products included ZINC, VITAMINS NOS and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 31-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2022, the patient experienced PYREXIA (Low fever under 100 Fahrenheit degrees), LYMPHADENOPATHY (Swollen lymph node on left arm pit/felt the lymph node was starting to swell), FATIGUE (Feeling tired) and FEELING ABNORMAL (Feeling horrible). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (Low fever under 100 Fahrenheit degrees), LYMPHADENOPATHY (Swollen lymph node on left arm pit/felt the lymph node was starting to swell), FATIGUE (Feeling tired) and FEELING ABNORMAL (Feeling horrible) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jun-2022, Body temperature: under 100 (Low) low fever under 100 degrees.         Other concomitant medication included Acetamidine for an unknown indication. Patient never tested positive for Covid 19 and patient believes patient might have had these symptoms because it is the first time that patient receives a Moderna vaccine.
started with a fever (over 100), body aches, chills, sweats, severe arm pain on Friday night. Continued all day Saturday and all day Sunday. Fever broke on Sunday night, pain in arm is still there today. Not as severe, but still painful to touch and move
Change in headache pattern, neck and shoulder pain, hand swelling, hand pain and stiffness, pain in right hip.
The patient presents following fall. 86 y/o male presents to the ED with multiple falls x3 days. Pt sts he has fallen approximately a total of 6 time. Pt sts his legs give out and sts he falls. Pt sts he has had hit his head a couple of times due to falling. Pt also c/o a occasional cough and sts his urine has been dark and is unknown sure why. Denies light headed, dizziness, fever, chills, N/V/D, CP, SOB, or any other symptoms.  The onset was 3  days ago.  The occurrence was multiple episodes.  The location where the incident occurred was at a nursing home.  Risk factors consist of age. (Covid 19 incidental finding)
Breakthrough case admission after 4 vaccines 1/26/21 Pfizer lot# EL9261;  MOderna 2/19/21 no lot#;  Moderna 3/19/21 no lot#;  9/27/21 Pfizer lot#FF2587
injection site got swollen and growing; injection site red; injection site hot; injection site itchy; A spontaneous report was received from a 33 year old female healthcare facility staff member who was participating in the mRNA-1273 Emergency Use Program and developed red, hot, itchy, swollen injection site that is expanding.   The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Dec 2020, approximately 7 days prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot# 025J20-2A) intramuscularly in the arm for prophylaxis of COVID-19 infection.   On 2 Jan 2021, the patient noted that the injection site became swollen, red, hot and itchy and was expanding with time. Treatment for the event included diphenhydramine every six hours and ibuprofen.   Action taken with mRNA-1273 in response to the event is not provided.   The outcome of the events, developed red, hot, itchy, swollen injection site that is expanding, were considered not  resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: ep695s) via an unspecified route of administration in the left arm on 15Mar2021 at 12:15 (at the age of 50-years) as a single dose for COVID-19 immunisation. Medical history included Vitamin D deficiency, Allergy induced Asthma and Sinus disorder. The patient was allergic to latex, nuts, dust, trees, grasses, certain topical creams, smoke, incense and sprays. Prior to vaccination, the patient was not diagnosed with COVID-19 and was not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and  ALAVERT for Decongestion from an unspecified dates. The patient experienced Tiredness on 15Mar2021 at 17:00 that lasted for two days even with 7.5 hours of sleep and the patient found it hard to fully wake up in the morning the day after the vaccination. The patient did not receive any treatment for Tiredness. The clinical outcome of Tiredness was recovered on 17Mar2021.   No follow-up attempts are needed. No further information is expected.
Headache; achenes in arm and legs; some tenderness in lymph node; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PAIN IN EXTREMITY (achenes in arm and legs) and LYMPH NODE PAIN (some tenderness in lymph node) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included Fall and Ministroke (In November.).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced HEADACHE (Headache), PAIN IN EXTREMITY (achenes in arm and legs) and LYMPH NODE PAIN (some tenderness in lymph node). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 325 mg. At the time of the report, HEADACHE (Headache), PAIN IN EXTREMITY (achenes in arm and legs) and LYMPH NODE PAIN (some tenderness in lymph node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
pt recv vax 26MAY95 & 22JUN95 pt devel chickenpox; No further details were provided;
Chest Pain, Fatigue , Chills, Sweats, Shiver's, shivering's, Sweating ,  Vomiting.  Tiredness, After #2 PFIZER shot  CT with contrast and with Nitroglycerine
The only thing that I would like to report is that my reaction was delayed compared to the other reports I have heard. I received my second vaccination on Friday and did fine for the entire weekend. I was slightly tired and took Tylenol to prevent any problems. By Monday morning (3rd day after), I felt terrible. I had the usual low grade temperature, extremely tired and I felt like I had a chest cold. I started feeling better by Friday morning (after 4 days). So my report is that I had the known symptoms but it was delayed with me and lasted a bit longer with me than others have reported.
Information has been received from a physician assistant concerning a 24 year old female with no medical history or concurrent condition who on 21-FEB-2010 developed hyperesthesia after receiving a dose of GARDASIL. Concomitant therapy included VALTREX. Approximately two or three days after receiving the vaccine, she complained of sensitivity to touches. The reporter wasn't sure if this vaccine dose was her second or third dose. The patient sought unspecified medical attention. At the time of report the patient had not recovered. Follow up information was received from a physician assistant on 24-FEB-2010 via telephone. It was reported the patient had received the third dose of GARDASIL at another physician's office. The patient complained of sensitivity to touch over her whole body. The patient was placed on therapy with NEURONTIN, 300 mg, twice a day for pain. The patient had a follow-up appointment with the P.A. in a couple of days. The information if the patient's OB-GYN physician was also provided. Additional information has been requested.
Information has been received from a licensed practical nurse concerning a 26 year old with a history of mild asthma who on 18-SEP-2007 was vaccinated with a dose of VAQTA. Concomitant vaccinations administered that same day included a dose of Japanese encephalitis vaccine, a dose of PNEUMOVAX-23, a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and dose of MENACTRA, and a dose of typhoid pills. Other concomitant medication included ORTHO EVRA. Subsequently the patient experienced chills, lack of appetite and a fever on an off. It was unknown whether medical attention was sought. No labs or diagnostic studies were performed. The patient was treated with ibuprofen (WYETH) which helped the symptoms subside. The patient's recovery status was unknown. There was no product quality complaint. Additional information has been requested.
fever,shaking uncontrollably, headache and body aches  on 1-29-2021 and 1-30-2021
Within 12 hours of receiving her second dose of SHINGRIX the patient reports redness, swelling and pain around the injection site. She reported to the pharmacy where the vaccine was given and she was counseled to follow up with her primary care physician. Swelling, redness and pain extended to an area >100 mm. Photographs were taken as documentation.